change is coming - philippine coalition against...
TRANSCRIPT
Change is Coming to Philippine NTP
23rd PhilCAT’s Annual Convention
August 18, 2016 Crowne Plaza Hotel Manila Galleria
Anna Marie Celina G. Garfin, MD, MM Disease Prevention and Control Bureau
Objectives
• To provide updates on the current situation of TB in the Philippines
• To share the direction of the DOH viz-a-viz the current national leadership
• To share a glimpse of the ongoing development of the 2017-2022 TB Strategic Plan
2016 End of the Millennium Development Goals,
Start of the Sustainable Development Goals,
Start of a new presidential administration.
Change is bound to happen!
Is it true for the TB Program?
Indicator 1983
(1st)
1997
(2nd)
2007
(3rd)
2016 (4th)
Prevalence of Xpert MTB (+)
------- ------- ------- ?
Prevalence of Smear (+)
6.6/1000 3.1/1000 2.0/1000 ?
Prevalence of Culture (+)
8.6/1000 8.1/1000 4.7/1000 ?
DOTS Strategy
Strengthened NTP
6-point agenda
Comparison of National TB Prevalence Surveys
2010-2016 PhilPACT
2015 Accomplishment - Impact
Impact Indicators
2016 Target Accomplishment 2015
(WHO estimate)
Remarks
Mortality rate 23/100,000 14/100,000 (13-14) Achieved
Incidence rate 246/100,000 322/100,000 (277-
370) Final verdict will be based on the results of the 2016
National TB Prevalence Survey
Prevalence rate 414/100,000
2015 Accomplishment - Outcome
Outcome Indicators 2016 Target 2015
Accomplishment Remarks
Case Notification rate 221/100,000 272/100,000 Achieved
Case Detection rate 90% 91% Achieved
Treatment Success rate
90% 92% Achieved
Notification rate of MDR TB
62% 27% Not
Achieved
Treatment Success rate MDR TB (2013 cohort)
75% 49% Not
Achieved
2015 Accomplishment - Output
TB Case notification 2015
Total cases notified 308,267
Total new and relapse 299,207
- % tested with rapid diagnostics at time of diagnosis 20%
- % with known HIV status 13%
- % pulmonary 97%
- % bacteriologically confirmed among pulmonary 36%
0
20
40
60
80
100
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
CDR, All forms Success Rate
Trend of Case Detection Rate (All Forms) and Treatment Success Rate, 2000 to 2015
TB in Children - Susceptible
• 2015 Case Finding on Children (0-14 years old)
• 35,873 (13% of all TB cases) children identified and started on treatment
• 6,700 cases of latent TB infection given Isoniazid Preventive Therapy (IPT)
• Treatment Success Rate – no data specific for children
TB in Children - Resistant
2011 2012 2013 2014 2015 MDR-TB Children 0-14 years old
12 7 15 16 30
• Treatment Success Rate: 50% • Lost to Follow-Up (Defaulters): 14% • Death Rate: 14%
0
10
20
30
40
50
60
70
80
90
100
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Public Public and Private
Contribution of the Private Sector (All Forms, 2003 to 2015)
14%
PMDT Enrolment per Region, 2015
0
200
400
600
800
1000
1200
1400
1 2 3 4A
4B 5 6 7 8 9 10
11
12
13
CAR
NCR
ARMM
Trend of Enrollment of Patients under PMDT, 1999-2015
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
New patients 7 15 86 56 22 99 191 134 315 530 569 870 2569 2056 2390 2010 4063
Cumulative 7 22 108 164 186 285 476 610 925 1455 2024 2894 5463 7519 9909 11919 15982
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
Trend of Treatment Outcome of Patients under PMDT 1999 to 2012
1999-2000
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
LosttoFf-up 9% 14% 23% 23% 15% 13% 18% 20% 25% 33% 38% 44% 36%
Died 9% 15% 11% 5% 8% 12% 17% 11% 10% 9% 14% 12% 13%
Failure 18% 14% 7% 0% 4% 1% 2% 4% 1% 2% 2% 2% 1%
Success 64% 57% 59% 73% 73% 74% 63% 63% 64% 57% 46% 41% 49%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Achievements – 2013 Joint Program Review
Considerable
progress 2011-2016
The 2016 Joint
Program Review
found the strategic
direction of the NTP
to be technically
sound and well
focused.
Case notification increasing
Overall program is well managed;
fully decentralized
Multi-sectoral &
high-level commitment for TB; TB law to be
passed
Innovation & uptake of new
tools, at all levels, reflects
commitment to quality
Proposed TB Law
will be considered a
flagship for the
region
Key Challenges
• Insufficient number of permanent human resources
• Services are not yet fully integrated – TB HIV, TB DM
• Very low uptake of IPT for children, low detection of TB in children
• Barriers to access continue: financial, geographic, knowledge, provider support according to patient needs
• Low detection and treatment outcome of drug resistant TB cases
• Supply management system is not yielding uninterrupted, quality drug or laboratory supplies
• Information flow is not reliable; limited use of data to enhance program implementation
• Sustainability of collaboration with the private sector
D
Innovate: Be bold to solve problems
B
Act on the TB Law, once passed
A
Develop a roadmap toward sustainability
C Embrace and scale-up new technologies,
medicines and approaches
Joint Program Review Recommendations
Millennium Development Goals
1990 to 2015
Considerations for 2017 and beyond activities
Sustainable Development Goals 2016 to 2030
By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected
tropical diseases and combat hepatitis, water-borne diseases and other
communicable diseases
Filipino families are entitled to…
The government is committed to…
Comprehensive range of services that protect everyone at all ages and all stages
Receive coordinated, appropriate, quality and respectful care
Financial freedom when utilizing health care services
Guarantee services that provide care for ALL LIFE STAGES & ADDRESS THE TRIPLE BURDEN OF DISEASES
Ensure these services are accessible in functional SERVICE DELIVERY NETWORK
Sustainably finance these services through UNIVERSAL HEALTH INSURANCE
All for Health towards Health for All Duterte Health Agenda
UNIVERSAL HEALTH INSURANCE
Our Strategies
A
C
H
I
E
V
E
Advance primary care and quality
Cover all Filipinos against financial catastrophe
Harness power of strategic health human resource
Invest in digital health and data for decision-making
Enforce standards, accountability and transparency
Value clients and patients
Elicit multi-sector, multi-stakeholder support for health
Pillar 1 Integrated
patient-centered TB care
and prevention
Pillar 2 Bold
policies and supportive
systems
Pillar 3 Intensified research
and innovation
The END TB Strategy: Pillars and Principles
Lecture of Diana Weil, WHO-HQ
2017-2022 NTP National Strategic Plan 6 Reform Areas
Governance
Service Delivery
Regulation
Financing
Information and
research
Human Resource
Objectives of 2017-2022 NSP
1. Ensure that all regions and 90% of LGUs are adopting multi-sectoral collaboration in implementing the Comprehensive Tuberculosis Elimination Plan (Governance)
2. Ensure adequate TB care providers who are providing patient centered TB services (Human resource development)
3. Increase to at least 90% of all health facilities and providers that are providing patient centered, integrated and expanded TB care and prevention services (Service delivery)
4. Make available quality TB products and diagnostic tools (Regulation)
5. Reduce to zero the proportion of affected families facing catastrophic costs due to TB among those seen in the TB DOTS network (Financing)
6. Improve utilization of adequate, timely and accurate TB information (Information Management)
2017-2022 NTP National Strategic Plan 5 Principles
One national plan but locally adapted
Led by DOH with strong public-private sector collaboration
Active participation of patients and communities
Promotion of human rights and equity
Efficient resource utilization
1
2
3
4
5
Commitments for 2017 to 2022
2015 2022 2030 2035
Baseline National Strategic Plan
SDG End TB Strategy
Reduction in the number of TB deaths from 2015 (14,000)
55% reduction (6,300)
90 % Reduction
(1,400)
95% Reduction
(400)
Reduction in TB incidence rate from 2015 (322/100,000)
35% reduction (209/100,000)
80% Reduction
(64/100,000)
90% Reduction
(32/100,000)
Catastrophic cost 0 0 0
What are the Changes?
TB Control
• Systematic screening of contacts
• Provision of Preventive Therapy
TB Elimination
1
What are the Changes?
• CUP partnership
• Private sector
Health Sector involvement
• DOH & other government agencies
• Private sector
• Patient groups
• Community
Multi-Sectoral involvement
2
What are the Changes?
Fragmented Service Delivery
• Service Delivery Network
• Integrated TB services
Network of Providers
4
What are the Changes?
Availability of Products
• FDC for children
• New drugs – Bedaquiline, shorter treatment regimen
Quality and safety of products
5
What are the Changes?
Passive casefinding
• Mass screening of inmates, urban poor
• TB caravans
Targeted active casefinding
6
What are the Changes?
Manual Paper-based reporting
• Integrated TB Information System
• Mandatory reporting of TB cases
• Contact tracing
Electronic Information System
7